Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

2,454

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

TAK-875

TAK-875 25 mg, tablets, orally, once daily and metformin ≥1500 mg or Maximum Tolerated Dose (MTD) for up to 104 weeks.

DRUG

TAK-875

TAK-875 50 mg, tablets, orally, once daily and metformin ≥1500 mg or MTD for up to 104 weeks.

DRUG

Glimepiride

Glimepiride 1 mg, tablets, orally, once daily (up-titrated to 2 mg after 1 week of treatment. Up-titrated to a maximum of 6 mg in 2 mg increments/down titrated if recurrent (or severe) hypoglycemia occurs) and metformin ≥1500 mg or MTD for up to 104 weeks.

Trial Locations (226)

Unknown

Dothan

Muscle Shoals

Goodyear

Phoenix

Tempe

Long Beach

Mission Hills

North Hollywood

Norwalk

Pismo Beach

Bradenton

Clearwater

Coral Gables

Hialeah

Orlando

Pembroke Pines

Decatur

Avon

Topeka

Oxon Hill

Flint

Jackson

Omaha

Elizabeth

Calabash

Charlotte

Greensboro

Mooresville

Morganton

Raleigh

Maumee

Oklahoma City

Greer

Spartanburg

Dallas

El Paso

Fort Worth

Houston

New Braunfels

San Antonio

Spring

Tomball

Salt Lake City

Burke

Hampton

Manassas

Buenos Aires

Ciudad Autonoma Buenos Aires

Corrientes

Córdoba

Rosario

Córdoba

Canberra

Brookvale

Mosman

Woy Woy

Canberra

Blagoevgrad

Gabrovo

Pleven

Plovdiv

Sevlievo

Sofia

Stara Zagora

Varna

Victoria

Oakville

Ottawa

Thornhill

Toronto

Laval

Longueuil

Mirabel

Pointe-Claire

Saint-Laurent

Bogotá

Medellín

Benátky nad Jizerou

Brno

Choceň

České Budějovice

Jindřichův Hradec

Mariánské Lázně

Olomouc

Ostrava

Ostrava - Moravska Ostrava

Ostrava - Vitkovice

Prague

Praha 4 - Krc

Znojmo

Paide

Rakvere

Saku

Tallinn

Tartu

Võru

Hong Kong

New Territories

Ashkelon

Beer Yaakov

Beersheba

Giv‘atayim

Hadera

Haifa

Holon

Jerusalem

Kfar Saba

Nahariya

Petah Tikva

Raanana

Ramat Gan

Rehovot

Rishon LeZiyyon

Safed

Tel Aviv

Jelgava

Limbaži

Ogre

Riga

Talsi

Valmiera

Alytus

Kaunas

Klaipėda

Vilnius

Kuala Lumpur

Malacca

Ipoh

Taiping

Taiping, Perak

Putrajaya

Petaling Jaya

Terengganu

Terengganu

Mexico City

Cuernavaca

Auckland

Christchurch

Hamilton

Palmerston North

Rotorua

Tauranga

Wellington

Cebu City

Davao City

Iloilo City

Lipa City

Quezon City

Tarlac City

Taytay

Bialystok

Bydgoszcz

Gdansk

Grodzisk Mazowiecki

Kamieniec Ząbkowicki

Katowice

Lodz

Lublin

Oświęcim

Parczew

Poznan

Puławy

Płock

Ruda Śląska

Rzeszów

Sopot

Torun

Wroclaw

Zgierz

Łęczyca

Bacau

Baia Mare

Bucharest

Constanța

Iași

Oradea

Ploieşti

Târgu Mureş

Timișoara

Kazan'

Kemerovo

Krasnoyarsk

Moscow

Novosibirsk

Saint Petersburg

Yaroslavl

Port Elizabeth

Bloemfontein

Johannesburg

Kempton Park

Krugersdorp

Pretoria

Durban

Middelburg

Cape Town

Somerset West

Stellenbosch

Worcester

Chia-Yi City

New Taipei City

Taichung

Tainan City

Taipei

Dnipropetrovsk

Ivano-Frankivsk

Kharkiv

Kiev

Kyiv

Luhansk

Lviv

Mykolayiv

Poltava

Ternopil

Vinnytsia

Zaporizhzhia

Cardiff

Cheadle

Plymouth

Hull

Bexhill-on-Sea

Watford

Thornton-Cleveleys

Liverpool

Northwood

Bath

Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY